Next Article in Journal
Differential Expression of Nitric Oxide Synthase Isoforms nNOS and iNOS in Patients with Non-Segmental Generalized Vitiligo
Next Article in Special Issue
Plasma Sphingolipids in Acute Pancreatitis
Previous Article in Journal
Genetic Polymorphism of miR-196a-2 is Associated with Bone Mineral Density (BMD)
Previous Article in Special Issue
Altered Leukocyte Sphingolipid Pathway in Breast Cancer
Article Menu
Issue 12 (December) cover image

Export Article

Open AccessReview

Translational Aspects of Sphingolipid Metabolism in Renal Disorders

Department of Anatomy, Cell Biology and Physiology, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon
Department of Medicine, Peggy and Harold Katz Family Drug Discovery Center, University of Miami, Miami, FL 33136, USA
Department of Radiation Oncology, Miller School of Medicine/Sylvester Cancer Center, University of Miami, Miami, FL 33136, USA
Department of Radiation Oncology, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2017, 18(12), 2528;
Received: 27 October 2017 / Revised: 16 November 2017 / Accepted: 17 November 2017 / Published: 25 November 2017
(This article belongs to the Special Issue Sphingolipids: Signals and Disease)
PDF [1307 KB, uploaded 29 November 2017]


Sphingolipids, long thought to be passive components of biological membranes with merely a structural role, have proved throughout the past decade to be major players in the pathogenesis of many human diseases. The study and characterization of several genetic disorders like Fabry’s and Tay Sachs, where sphingolipid metabolism is disrupted, leading to a systemic array of clinical symptoms, have indeed helped elucidate and appreciate the importance of sphingolipids and their metabolites as active signaling molecules. In addition to being involved in dynamic cellular processes like apoptosis, senescence and differentiation, sphingolipids are implicated in critical physiological functions such as immune responses and pathophysiological conditions like inflammation and insulin resistance. Interestingly, the kidneys are among the most sensitive organ systems to sphingolipid alterations, rendering these molecules and the enzymes involved in their metabolism, promising therapeutic targets for numerous nephropathic complications that stand behind podocyte injury and renal failure. View Full-Text
Keywords: sphingolipids; Fabry’s disease; sphingolipid metabolism; podocytes; renal injury; renal failure sphingolipids; Fabry’s disease; sphingolipid metabolism; podocytes; renal injury; renal failure

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Abou Daher, A.; El Jalkh, T.; Eid, A.A.; Fornoni, A.; Marples, B.; Zeidan, Y.H. Translational Aspects of Sphingolipid Metabolism in Renal Disorders. Int. J. Mol. Sci. 2017, 18, 2528.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top